Streetbeat News

BGXX

Bright Green Corporation

https://www.brightgreen.us

Industry

Drug Manufacturers - Specialty & Generic

Bright Green Corporation grows, manufactures, and sells cannabis and cannabis-related products legally under federal and state laws for research, pharmaceutical applications, and export. The company was incorporated in 2019 and is based in Fort Lauderdale, Florida.

Open

0.07

Mkt cap

14M

Volume

7.3K

High

0.09

P/E Ratio

-1.51

52-wk high

0.54

Low

0.07

Div yield

N/A

52-wk low

0.03

Stitch Fix (NASDAQ:SFIX) shares surged 18% in pre-market trading after reporting better-than-expected Q3 financial results. Other notable pre-market movers include Actelis Networks (NASDAQ:ASNS) up 794%, mF International (NASDAQ:MFI) up 108.4%, and Hewlett Packard Enterprise (NYSE:HPE) up 14.7%.

Portfolio Pulse from Avi Kapoor

June 05, 2024 | 9:27 am

The article highlights the performance of 12 health care stocks during Monday's after-market session. Notable gainers include FibroGen, Candel Therapeutics, and RAPT Therapeutics, while significant losers include Bright Green, Nanoviricides, and Concord Medical Services.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 8:31 pm

The article highlights the pre-market movements of 12 health care stocks on Monday. Notable gainers include Bio-Path Holdings (BPTH) up 70.4%, Molecular Partners (MOLN) up 21.72%, and Structure Therapeutics (GPCR) up 19.23%. Significant losers include Galera Therapeutics (GRTX) down 36.5%, Portage Biotech (PRTG) down 20.99%, and iSpecimen (ISPC) down 17.4%.

Portfolio Pulse from Benzinga Insights

June 03, 2024 | 12:07 pm

The article highlights the performance of 12 healthcare stocks during Friday's after-market session. Liquidia, Adagene, and Atara Biotherapeutics were among the top gainers, while Portage Biotech, Kintara Therapeutics, and Bright Green saw significant declines.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 8:32 pm

Bright Green Corporation has received a Notice of Allowance for its US patent application on a cannabinoid-based treatment for post-operative conditions. This development could potentially enhance the company's market position in the medical cannabis sector.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 7:58 pm

The article highlights the pre-market movements of various health care stocks on Friday. Notable gainers include Novo Integrated Sciences (NVOS), Adaptimmune Therapeutics (ADAP), and Bionomics (BNOX). Significant losers include Summit Therapeutics (SMMT), Genfit (GNFT), and Veeva Systems (VEEV).

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 12:06 pm

In Friday's after-market session, several healthcare stocks showed notable movements. Bluejay Diagnostics, China Pharma Holdings, and Imunon were among the top gainers, with increases of 11.0%, 10.15%, and 7.63% respectively. On the losing end, Compass Therapeutics, Akanda, and Portage Biotech saw significant declines. Accolade also rose by 5.83% following their Q4 earnings release.

Portfolio Pulse from Benzinga Insights

April 26, 2024 | 8:31 pm

In Thursday's after-market session, several health care stocks showed significant movement. Ontrak, Ocuphire Pharma, and Lyell Immunopharma were among the top gainers, with Ontrak leading at an 18.7% increase. Conversely, Motus GI Holdings, Acorda Therapeutics, and Nurix Therapeutics were the top losers, with Motus GI Holdings experiencing a 32.6% decline. Notably, Nurix Therapeutics' drop was following their Q1 earnings report.

Portfolio Pulse from Benzinga Insights

April 11, 2024 | 8:31 pm

In Friday's after-market session, several healthcare stocks showed significant movement. Salarius Pharmaceuticals, Masimo, and Vicarious Surgical were among the top gainers, with Salarius Pharmaceuticals leading with a 33.9% increase. On the downside, NextCure, Rockwell Medical, and Mesoblast experienced declines, with NextCure dropping 9.5% following its Q4 earnings report. These movements reflect the dynamic nature of the healthcare stock market.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 9:33 pm

In Thursday's pre-market session, several healthcare stocks showed significant movement. Aptorum Gr, Nuvectis Pharma, and Bright Green were among the top gainers, with shares increasing by 47.1%, 23.65%, and 20.99% respectively. On the losing side, Spruce Biosciences saw a dramatic drop of 78% following its Q4 earnings report. Other notable decliners include Kintara Therapeutics and Nuvation Bio.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 1:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.